A global rise in antimicrobial resistant infections has resulted in an estimated 4.95 million deaths in 2019.1,2 The WHO 2024 priority pathogens list includes 24 notorious antimicrobial resistant organisms identified as targets for research and development (R&D) and public health interventions.2 The list aims to address the ever-changing landscape of global antimicrobial resistance (AMR) and prioritize R&D and investments in AMR.
The WHO priority